Trials / Terminated
TerminatedNCT06135727
Screening Protocol
Data Collection for Development of Topcon Health Score
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Topcon Corporation · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to collect data for the development and validation a screening process using aggregate data. In this study, data collection will encompass both retrospective and prospective approaches across multiple sites in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Maestro2 OCT | 3D Wide (12mmx9mm) OCT scan using the Maestro (Topcon, Japan) |
Timeline
- Start date
- 2023-11-07
- Primary completion
- 2024-08-02
- Completion
- 2024-08-02
- First posted
- 2023-11-18
- Last updated
- 2025-09-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06135727. Inclusion in this directory is not an endorsement.